Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

"Pharmaceuticals" Company Results for March 2013 Quarter 

Here are the latest quarterly results of India's top pharmaceuticals companies. For more detailed updates, read our pharmaceuticals sector report and check the latest pharmaceuticals sector stock quotes.

Click on title to sort Mar 2012 Mar 2013 YoY %-Change   Get More Info
 Name
asc
Net Sales 
(Rs m) 
PAT 
(Rs m) 
Net Sales 
(Rs m) 
PAT 
(Rs m) 
Net Sales 
(%) 
PAT 
(%) 
P/E* 
(x) 
AJANTA PHARMA 1,761 236 2,494 271 41.6% 14.8% 25.4  More Info 
BROOKS LAB 145 25 223 54 54.0% 117.2% 112.2  More Info 
DR. REDDYS LAB 26,585 3,416 33,399 5,683 25.6% 66.4% 81.7  More Info 
GENNEX LAB. 59 4 84 3 42.2% -24.3% 7.0  More Info 
GUJ.THEMIS. 54 49 73 -0 36.6% -100.9% 52.3  More Info 
IPCA LABS 5,611 766 6,717 754 19.7% -1.5% 79.4  More Info 
J.B.CHEMICALS 1,548 89 2,051 198 32.5% 122.8% 26.8  More Info 
MAKERS LAB. 125 -2 163 10 31.1% N.A. 22.2  More Info 
NATURAL CAPS 120 10 136 26 13.3% 164.0% 43.2  More Info 
NEWTIME INFRASTRUCTURE 2 1 0 0 -77.0% -90.0% 172.9  More Info 
PANCHSHEEL ORG 99 9 80 0 -19.3% -99.0% 8.0  More Info 
SCANDENT IMAGING 0 0 6 1 N.A. 2,575.0% N.A.  More Info 
SHUKRA PHARMA 4 -75 16 -24 257.0% N.A. 13.2  More Info 
SUVEN LIFE SCIENCES 625 83 747 86 19.5% 3.9% N.A.  More Info 
SYNCOM FORMULATIONS 269 -8 348 11 29.4% N.A. 10.7  More Info 
THEMIS MEDICARE 347 -51 253 -43 -26.9% N.A. 94.3  More Info 
TORRENT PHARMA 6,740 -10 8,710 1,110 29.2% N.A. 52.0  More Info 
VISTA PHARMA 15 -1 18 1 16.6% N.A. N.A.  More Info 
VIVANZA BIOSCIENCES 0 -0 0 -5 N.A. N.A. 7,284.5  More Info 
WOCKHARDT 11,756 -1,977 14,855 3,348 26.4% N.A. N.A.  More Info 
WOCKHARDT 11,756 -1,977 14,855 3,348 26.4% N.A. N.A.  More Info 
Sector Aggregate 67,620 586 85,229 14,831 26.0% 2,432.9%  

* Trailing 12 months earnings, excluding extraordinary / exceptional items.

Dec 2012 Results  |  Jun 2013 Results  |  Latest Quarter Results  |  View All Results